Neogen Corporation $NEOG Shares Acquired by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL increased its holdings in shares of Neogen Corporation (NASDAQ:NEOG) by 79.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 199,900 shares of the company’s stock after purchasing an additional 88,400 shares during the quarter. Gamco Investors INC. ET AL owned approximately 0.09% of Neogen worth $1,857,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Huntington National Bank increased its stake in Neogen by 8.4% in the fourth quarter. Huntington National Bank now owns 13,552 shares of the company’s stock valued at $95,000 after purchasing an additional 1,045 shares during the last quarter. ProShare Advisors LLC lifted its position in shares of Neogen by 3.2% during the 4th quarter. ProShare Advisors LLC now owns 42,509 shares of the company’s stock worth $297,000 after buying an additional 1,331 shares during the last quarter. State of Alaska Department of Revenue lifted its position in shares of Neogen by 1.2% during the 4th quarter. State of Alaska Department of Revenue now owns 110,645 shares of the company’s stock worth $773,000 after buying an additional 1,353 shares during the last quarter. Evergreen Capital Management LLC boosted its holdings in shares of Neogen by 12.3% in the 4th quarter. Evergreen Capital Management LLC now owns 13,753 shares of the company’s stock valued at $96,000 after buying an additional 1,504 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV boosted its holdings in shares of Neogen by 10.1% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 17,837 shares of the company’s stock valued at $125,000 after buying an additional 1,638 shares in the last quarter. 96.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Weiss Ratings downgraded shares of Neogen from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $10.67.

Neogen Price Performance

NEOG stock opened at $9.19 on Wednesday. The company has a market capitalization of $2.00 billion, a P/E ratio of -3.28, a PEG ratio of 4.18 and a beta of 1.80. Neogen Corporation has a twelve month low of $4.56 and a twelve month high of $11.43. The business has a 50 day simple moving average of $9.31 and a 200-day simple moving average of $9.59. The company has a current ratio of 3.92, a quick ratio of 2.84 and a debt-to-equity ratio of 0.38.

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user?friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.